DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Zindoxifene
Zindoxifene
Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective
(12) United States Patent (10) Patent No.: US 6,927,224 B2 Kaltenbach Et Al
In Vitro Estrogenic Actions in Rat and Human Cells of Hydroxylated Derivatives of D16726 (Zindoxifene), an Agent with Known Antimammary Cancer Activity in Vivo1
Pharmaceutical Appendix to the Tariff Schedule 2
(12) United States Patent (10) Patent No.: US 8,623.422 B2 Hansen Et Al
(12) United States Patent (10) Patent No.: US 8.242,079 B2 Varadhachary Et Al
Phase I/II Study Ofthe Anti-Oestrogen Zindoxifene
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,853,266 B2 Dalton Et Al
Identification of Unknown Residues
Stembook 2018.Pdf
Canå“Rresearch VOLUME 48 €¢NUMBER 4 €¢Cnrea8•PP759-1048
Chemopreventive Activity of Tamoxifen, N-(4-Hydroxyphenyl
(10) Patent No.: US 8080682 B2
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
The Pharmacologic Modulation of Estrogen Receptor Activity
Top View
The Discovery and Development of Selective Estrogen Receptor Modulators (Serms) for Clinical Practice
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Customs Tariff - Schedule
Ep 2106212 B1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2006) (Rev
Synthesis and Biological Assessment of Organometallic Tamoxifen Derivatives for the Diagnosis and the Treatment of Breast Cancer Anh Nguyen
50Th Anniversary of the First Clinical Trial with ICI 46,474 (Tamoxifen): Then What Happened?
Interaction of Cancerostatic Drugs in Vitro Immunocompetent and Pre-Irradiated Normal Mice
(12) United States Patent (10) Patent No.: US 8.403,954 B2 Santin Et Al